Interferon alfa plus ribavirin in chronic hepatitis C relapsers and non-responders to previous interferon alfa course

被引：3
|
作者：
Salmerón, J
Vivaldi, RM
De la Mata, M
Romero, M
Moreno, JP
Aguilar, J
Palacios, A
Nogueras, F
Vignote, M
Alcántara, R
Suarez, E
Andrade, R
Rodriguez, L
Sanchez, H
Quintero, D
机构：
来源：
JOURNAL OF HEPATOLOGY | 2000年 / 32卷
关键词：
D O I：
10.1016/S0168-8278(00)81037-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [31] Efficacy of ribavirin plus interferon-alfa in elderly patients with chronic hepatitis C
    Honda, T.
    Katano, Y.
    Urano, F.
    Hayashi, K.
    Ishigami, M.
    Nakano, I.
    Yoshioka, K.
    Toyoda, H.
    Kumada, T.
    Goto, H.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S227 - S227
  • [32] Induction therapy in combination with ribavirin for interferon non-responders and relapsers.
    Perrillo, RP
    Murugan, N
    Denham, C
    Totaro, R
    HEPATOLOGY, 2000, 32 (04) : 350A - 350A
  • [33] OVERALL SAFETY PROFILE OF BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2A/RIBAVIRIN IN GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN
    Flamm, Steven L.
    Lawitz, Eric
    Jacobson, Ira M.
    Bourliere, Marc
    Hezode, Christophe
    Vierling, John M.
    Niederau, Claus
    Sherman, Morris
    Bacon, Bruce R.
    Pedicone, Lisa
    Goteti, Venkata S.
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Poordad, F. Fred
    HEPATOLOGY, 2011, 54 : 838A - 838A
  • [34] Efficacy of interferon plus ribavirin in chronic hepatitis C patients non responders to interferon alone
    Picciotto, A
    Campo, N
    Torre, F
    Brizzolara, R
    Sinelli, N
    Celle, G
    HEPATOLOGY, 1998, 28 (04) : 479A - 479A
  • [35] PILOT-STUDY OF COMBINATION THERAPY WITH RIBAVIRIN PLUS INTERFERON-ALFA FOR INTERFERON ALFA-RESISTANT CHRONIC HEPATITIS-C
    BRILLANTI, S
    GARSON, J
    FOLI, M
    WHITBY, K
    DEAVILLE, R
    MASCI, C
    MIGLIOLI, M
    BARBARA, L
    GASTROENTEROLOGY, 1994, 107 (03) : 812 - 817
  • [36] Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C
    Davis, GL
    SEMINARS IN LIVER DISEASE, 1999, 19 : 49 - 55
  • [37] High Dose Ribavirin and Peginterferon for Chronic Hepatitis C Non-responders or Relapsers
    Gara, Naveen
    Abdalla, Adil A.
    Rivera, Elenita M.
    Zhao, Xiongce
    Fryzek, Nancy
    Noureddin, Mazen
    Sarkar, Souvik
    Heller, Theo
    Rotman, Yaron
    Doo, Edward
    Liang, T. Jake
    Hoofnagle, Jay H.
    Ghany, Marc G.
    HEPATOLOGY, 2012, 56 : 1049A - 1049A
  • [38] Efficacy of the treatment with interferon, ribavirin and amantadine, in patients with hepatitis C non-responders or relapsers to the conventional therapy.
    Carmen, SE
    HEPATOLOGY, 2002, 36 (04) : 588A - 588A
  • [39] Predictive factors of a beneficial response to combination therapy of chronic hepatitis C in non-responders or relapsers to previous interferon treatment.
    Akarca, US
    Sayiner, A
    Ersoz, G
    Gunsar, F
    Ozacar, T
    Batur, Y
    HEPATOLOGY, 1999, 30 (04) : 631A - 631A
  • [40] A comparison of combination therapy with interferon and ribavirin vs interferon and amantadine in interferon non-responders with chronic hepatitis C.
    Khalili, M
    Olmeda, M
    Denham, CB
    Perrillo, RP
    HEPATOLOGY, 1998, 28 (04) : 169A - 169A
12345